Quotables
"We are probably nearing the limit of all we can know about astronomy."
Simon Newcomb, astronomer ; 1888
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120128728 | Compositions Comprising Amphotericin B The present invention comprises compositions and formulations comprising amphotericin B comprising less than 10% degradants, compositions and formulations comprising amphotericin B with one or more excipients, methods of making amphotericin B compositions and formulatio... | 05/24/2012 |
| 20120128741 | MODIFIED HYALURONIC ACID POLYMER COMPOSITIONS AND RELATED METHODS The present application provides compositions comprising hyaluronic acid having low levels of functional group modification, mixtures formed by controlled reaction of such lightly modified hyaluronic acid with suitable difunctional or multi-functional crosslinkers, and ... | 05/24/2012 |
| 20120128734 | Oral Delivery Product An oral delivery product comprising a semi-permeable pouch designed for delivery of an active agent in the oral cavity of a subject. The pouch encloses multiple particles, and the particles are alginate matrices that comprise an active agent, e.g. nicotine. The alginate... | 05/24/2012 |
| 20120128737 | COMPOSITIONS FOR TREATING DEGENERATIVE JOINT DISEASES In order to provide a composition for the treatment of degenerative joint diseases with an improved efficacy, it is proposed that the composition comprises collagen hydrolysate and rosehip powder and/or extract, wherein the weight ratio of collagen hydrolysate to rosehi... | 05/24/2012 |
| 20120125325 | THE USE OF AMLEXANOX IN THE THERAPY OF NEUTROPHIL-DRIVEN DISEASES An agent, which is amlexanox, is useful in the therapy of a disease associated with neutrophilia.... | 05/24/2012 |
| 20120128740 | NANOSTRUCTURED SILDENAFIL BASE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND CO-CRYSTALS, COMPOSITIONS OF THEM, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM The present invention is directed to nanostructured (nanoparticulated) Sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions containing them, process for the preparation thereof and pharmaceutical compositions containing them. The nanopart... | 05/24/2012 |
| 20120128782 | Multicomponent Degradable Cationic Polymers Degradable polymers were synthesized that self-assemble with DNA to form particles that are effective for gene delivery. Small changes to polymer synthesis conditions, particle formulation conditions, and polymer structure provides significant changes to efficacy in a c... | 05/24/2012 |
| 20120130435 | COMPOSITIONS AND METHODS FOR ARTHRODETIC PROCEDURES The present invention provides compositions and methods for facilitating fusion of bones in a joint. The present invention provides compositions and methods for promoting fusion of bones in arthrodetic procedures. In one embodiment, a method of performing an arthrodetic... | 05/24/2012 |
| 20120128732 | COMBINATIONS AND MODES OF ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY The present invention provides combination therapy methods of treating a proliferative disease (such as cancer) comprising a first therapy comprising administering to an individual an effective amount of a taxane in a nanoparticle composition, and a second therapy which... | 05/24/2012 |
| 20120128738 | Theobromine for the Treatment of Cough The present invention is theobromine as an active agent to be delivered via the inhaled route, for the treatment of cough.... | 05/24/2012 |
| 20120128729 | Gallium Formulation For The Treatment And Prevention of Infectious Diseases A method and composition for treatment of bacterial infections caused by gram negative or gram positive bacteria such as Staphylococcus aureus, Rhodococcus equi, Mycobacterium tuberculosis, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeru... | 05/24/2012 |
| 20120128590 | NANOPARTICLE DELIVERY SYSTEMS FOR MEMBRANE-INTEGRATING PEPTIDES Compositions which comprise emulsions of nanoparticles for delivery of membrane-integrating peptides are described. The nanoparticles comprise a liquid hydrophobic core coated with a lipid/surfactant layer which contains the membrane-integrating peptides. Methods to use... | 05/24/2012 |
| 20120128730 | COMPOSITIONS AND METHODS FOR ONCE-DAILY TREATMENT OF OBSESSIVE COMPULSIVE DISORDER WITH ONDANSETRON Compositions for once-daily administration of ondansetron are described. Compositions include a core, a semi-permeable membrane disposed generally around the core, an orifice in the semi-permeable membrane in fluid communication with the core, and a coating having a fir... | 05/24/2012 |
| 20120128739 | THREE-DIMENSIONAL NANOSTRUCTURED HYBRID SCAFFOLD AND MANUFACTURE THEREOF A method of making a three-dimensional biocompatible scaffold capable of supporting cell activities such as growth and differentiation, the method includes providing a supporting grid that forms an open network and provides mechanical support of a second biocompatible m... | 05/24/2012 |
| 20120128742 | SOLID ORAL FORMULATIONS AND CRYSTALLINE FORMS OF AN INHIBITOR OF APOPTOSIS PROTEIN The present disclosure relates to crystalline form of (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide, salts and hydrates thereof. This disclosure also relates to solid oral formulation of (S)... | 05/24/2012 |
| 20120128777 | COMPOSITIONS CONTAINING LIPID MICRO- OR NANOPARTICLES FOR THE ENHANCEMENT OF THE DERMAL ACTION OF SOLID PARTICLES The invention is related to compositions which can be used as dermal formulations for supporting the skin to restore normal conditions in case of e.g. irritated skin, or to support medical therapy of skin with atopic dermatitis symptoms, atopic dermatitis, psoriasis or ... | 05/24/2012 |
| 20120129134 | Light-Curable Bone Growth Material for Treating Dental Bone Defects Improved compositions comprising a mixture of particulate bone growth material and polymeric carrier are provided. The particulate is preferably porous, resorbable, anorganic bone material. The polymeric carrier can be light-cured to form a cross-linked, biodegradable h... | 05/24/2012 |
| 20120128735 | METHODS OF TREATMENT USING A GASTRIC RETAINED GABAPENTIN DOSAGE A method of treatment for epilepsy and other disease states is described, which comprises delivery of gabapentin in a gastric retained dosage form.... | 05/24/2012 |
| 20120128733 | PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE DRUGS, CONTRACEPTIVE KITS COMPRISING ACTIVE DRUGS, AND METHODS OF ADMINISTERING THE SAME The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may ... | 05/24/2012 |
| 20120128736 | OIL-IN-WATER EMULSION OF MOMETASONE Novel pharmaceutical compositions of mometasone or a pharmaceutically acceptable derivate thereof in the form of an oil-in-water emulsion, notably a cream. The composition has excellent stability and therapeutic effect. The compositions contain mometasone in micronised ... | 05/24/2012 |
| 20120128768 | ACTIVE SUBSTANCE COMBINATION COMPRISING A COMPOUND WITH NPY RECEPTOR AFFINITY AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY The present invention relates to an active substance combination comprising at least one compound with neuropeptide Y-receptor affinity and at least one compound with 5-HT6 receptor affinity, a medicament comprising said active substance combination, and the use of said... | 05/24/2012 |
| 20120128749 | COMPOSITION AND PROCESS FOR PRODUCTION THEREOF Disclosed are: a composition which enables the more effective development of the efficacy of a water-soluble drug in a solution containing the drug; and a dispersion in which a hydrophobic drug can be dispersed stably without requiring the use of any surfactant. Specifi... | 05/24/2012 |
| 20120128731 | BIOCOMPATIBLE CARRIER AND METHOD FOR FABRICATING THE SAME The invention provides a biocompatible carrier and method for fabricating the same. The biocompatible carrier includes: a gel, and a plurality of metal nanoparticles, an organic compound or combinations thereof embedded in the gel, wherein the metal nanoparticles, the o... | 05/24/2012 |
| 20120109044 | PREVENTION OF MYOCARDIAL INFRACTION INDUCED VENTRICULAR EXPANSION AND REMODELING A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion... | 05/03/2012 |
| 20120107405 | METHOD FOR THE DRY DISPERSION OF NANOPARTICLES AND THE PRODUCTION OF HIERARCHICAL STRUCTURES AND COATINGS The invention relates to a method for the dispersion of synthetic or natural nanoparticles and nanocomposite materials and to the use thereof in different sectors including those of ceramics, coatings, polymers, construction, paints, catalysis, pharmaceuticals and powde... | 05/03/2012 |
| 20120109051 | DEVICES, METHODS, AND KITS FOR TASTE MODIFICATION AND CONTROLLING FOOD INTAKE Disclosed are various embodiments of intra-oral taste modification devices, both erodible and non-erodible, and methods for using the devices, and methods and kits for making the devices, for controlling food intake by reducing the desire to eat highly sweetened foods a... | 05/03/2012 |
| 20120107372 | RECOMBINANT GELATINS The invention concerns a recombinant CBE gelatin and recombinant gelatins having multimers of the CBEmonomersequence that are of particular use in several applications involving cell attachment such as in cell culture work and applications involving cell cultures of anc... | 05/03/2012 |
| 20120107396 | Compositions For The Treatment of Central Nervous System Disorders Including Depression Employing Novel Drug Combination Therapy To Reduce Suicidality In Patients Described herein are novel methods and formulations for reducing suicidality in human subjects. Such formulations and methods are a combination of lithium and one or more other CNS therapeutic agents such as anti-depressant, mood-stabilizing, anxiolytic, anticonvulsant,... | 05/03/2012 |
| 20120110683 | NON-HUMAN ANIMAL MODEL OF MYOCARDIAL INFARCTION AND METHOD FOR CREATING THE SAME The present invention provides a non-human animal model of myocardial infarction, which can be created by a less invasive method, shows an extremely low mortality during and after surgical induction of myocardial infarction, ensures the blood reflow after necrosis of ca... | 05/03/2012 |
| 20120107368 | COMPRESSIBLE TABLET MATERIAL HAVING AN OIL-CONTAINING ACTIVE SUBSTANCE, TABLET AS WELL AS METHOD AND DEVICE FOR THE PRODUCTION THEREOF The invention relates to a compressible tablet material comprising the following components:
| 05/03/2012 |
| 20120107367 | Site-Specific Intestinal Delivery of Adsorbents, Alone or in Combination with Degrading Molecules Compositions which deliver adsorbents, alone or in combination with active drug “degrading molecules,” in a site-specific manner to the intestine, and which eliminate or at least lower the concentration of residual unwanted material within the intestine, and methods... | 05/03/2012 |
| 20120107369 | Polymers and Hydrogels Methods and compositions related polymers and hydrogels. In some cases to biodegradable hydrogels for use in medical applications are disclosed. The polymers and hydrogels may be produced from cross-linked dextran and poly(epoxides). The poly(epoxides) may be poloxamers... | 05/03/2012 |
| 20120107365 | FILMS AND PARTICLES Described herein are compounds and processes that can be used to prepare polymer-based films, particles, gels and related compositions, and processes for delivery of agents, and other uses.... | 05/03/2012 |
| 20120107241 | Particles for Inhalation Having Sustained Release Properties The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to particles suitable for use in the method. In particular, the invention relates... | 05/03/2012 |
| 20120107366 | Block Copolymer Systems and Their Use in Medical Devices The present disclosure relates to block copolymers, methods for their production, and the use of these copolymers in medical devices. In embodiments, the block copolymers may be used in tissue reinforcement including, for example, in hernia repair. The copolymers posses... | 05/03/2012 |
| 20120107370 | METHODS AND COMPOSITIONS FOR TREATING HIV-ASSOCIATED DIARRHEA Presented herein are methods for treating diarrhea by administering to a patient in need thereof, an inhibitor of chloride-ion transport in an amount sufficient to treat diarrhea. Treatment of diarrhea includes the treatment of the diarrhea as well as the pain, abdomina... | 05/03/2012 |
| 20120107382 | ARTICLES INCORPORATING ABSORBENT POLYMER AND CERAGENIN COMPOUND An absorbent article includes an absorbent polymer and a ceragenin compound. The ceragenin compound has a sterol group and a plurality of cationic groups that mimic naturally occurring antimicrobial peptides. The ceragenin compound is associated with the absorbent polym... | 05/03/2012 |
| 20120107378 | HIGH STRENGTH CARBO SUBSTANCES A black colouring substance, comprising carbo vegetabilis as a black pigment. The colouring substance may be used as a colouring agent in the manufacture of e.g. food and pharmaceutical products.... | 05/03/2012 |
| 20120107375 | ANTIMICROBIAL MATERIAL An antimicrobial material comprises propolis dispersed within a solid carrier. The antimicrobial material is preferably in the form of a film The carrier may be a polymeric material.... | 05/03/2012 |
| 20120107374 | COENZYME Q10-CONTAINING COMPOSITION The coenzyme Q10-containing liquid composition is obtained by dispersing and emulsifying coenzyme Q10 in an aqueous liquid containing a water-soluble substance consisting of octenylsuccinate starch and dextrin, and glycerin. The liquid composition ... | 05/03/2012 |
